Internal: Archive

european projects provide no easy solutions

This content was published on May 17, 2006 Philippe Renaud, a nanotechnology specialist at the Federal Institute of Technology in Lausanne, adds that focusing only on European Union targets could be counterproductive. Swiss researchers have taken part in the fourth, fifth and sixth European framework programmes. These programmes have been the most important tools of the EU’s research and development policies. swissinfo: What…

swiss talents call boston home

This content was published on May 17, 2006 swissinfo caught up with two Swiss scientists to find out what benefits they derive from working in the United States. Olivier de Weck is an assistant professor at the Massachusetts Institute of Technology (MIT) in Cambridge. For the past 12 years, he’s called the US home and teaches courses at MIT’s engineering systems division. He…

fuel for thought

This content was published on May 17, 2006 At the Paul Scherrer Institute not far from Zurich, researchers are testing both promising and lesser-known technology to answer the coming energy crunch. A small car developed at the institute in Villigen recently made headlines far and wide. Built in collaboration with tyre maker Michelin, it was neither fast nor stylish. But what it lacked…

scientists get on board with alinghi

This content was published on May 17, 2006 Switzerland’s Alinghi syndicate is relying on the institute to give it a technological edge over its challengers in sailing’s most prestigious event. Ernesto Bertarelli, head of the Alinghi team, signed up the institute as the official scientific partner in 2001. After winning the Cup in 2003, the syndicate decided to pursue the collaboration. Four of…

scents and tastes to delight the senses

This content was published on May 17, 2006 At the firm’s research facility just outside Zurich, scientists aren’t just busy mixing chemicals, but grappling with some of nature’s most alluring qualities. For Roman Kaiser, Givaudan’s own fragrance hunter, discoveries take place a long way away from his laboratory in Dübendorf. For years, he’s picked up his kitbag and headed off to exotic locations,…

containers send home news of long journey

This content was published on May 17, 2006 Known as Trec, or Tamper Resistant Embedded Controller, it could become the cornerstone of the company’s global surveillance programme. IBM’s Secure Trade Lane responds to the need for data on shipments in the transport industry amid heightened security fears. According to the company, the logistics industry is fragmented and cannot track shipments along the entire…

cancer drug beats back killer disease

This content was published on May 17, 2006 But while Glivec has proven successful at halting the spread of cancer cells related to the blood disease chronic myeloid leukaemia (CML), it is no cure. Until Glivec, Novartis had been a bit-player in the lucrative cancer treatment market. The product has earned more than $2.1 billion (SFr2.67 billion) in 2005, with sales increasing by…

millions benefit from swiss clear thinking

This content was published on May 17, 2006 But two Swiss systems with low-tech approaches show that unsafe water need not be a problem. Bulane, a Geneva-based company, has developed the Watalys, a system that produces a chlorine disinfectant. The Sodis foundation is promoting the use of plastic bottles to purify water. The Watalys can hardly be called high-tech. Its development was prompted…

novartis at home in cambridge

This content was published on May 17, 2006 But while the company’s scientists turn to the United States as they seek new drugs, Novartis has not completely abandoned research in Switzerland. In Cambridge, Novartis has three sites, but the firm’s showcase is an old sweet factory building it has turned into a designer research complex. It is located right next door to the…

paraplegics see glimmer of hope

This content was published on May 17, 2006 Schwab told swissinfo that science has progressed from the point where there was no hope of mobility to the stage where clinical trials may not be far off. The chairman of Zurich’s Neuroscience Center has been investigating the molecular mechanisms responsible for the decreased capacity of the adult central nervous system to regenerate after an…

Internal: Archive

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Internal: Archive

More

european projects provide no easy solutions

More

swiss talents call boston home

More

fuel for thought

More

scientists get on board with alinghi

More

scents and tastes to delight the senses

More

containers send home news of long journey

More

cancer drug beats back killer disease

More

millions benefit from swiss clear thinking

More

novartis at home in cambridge

More

paraplegics see glimmer of hope

Popular Stories

Most Discussed